View in EDS HTML Full Text PDF Full Text

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.

Saved in:
Bibliographic Details
Title: Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Authors: Baert T; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany., Vankerckhoven A; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium., Riva M; Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium., Van Hoylandt A; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium., Thirion G; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium., Holger G; Vascular Patterning Lab, Center for Cancer Biology, VIB, KU Leuven, Leuven, Belgium., Mathivet T; Vascular Patterning Lab, Center for Cancer Biology, VIB, KU Leuven, Leuven, Belgium.; PARCC, HEGP Institute (team 9), INSERM U970, Université Paris Descartes, Paris, France., Vergote I; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory of Gynecologic Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven (UZ Leuven), Leuven, Belgium., Coosemans A; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven (UZ Leuven), Leuven, Belgium.
Source: Frontiers in immunology [Front Immunol] 2019 Jun 04; Vol. 10, pp. 1273. Date of Electronic Publication: 2019 Jun 04 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31214202
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baert+T%22">Baert T</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecology and Gynecologic Oncology, Kliniken Essen Mitte, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Vankerckhoven+A%22">Vankerckhoven A</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Riva+M%22">Riva M</searchLink>; Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Hoylandt+A%22">Van Hoylandt A</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Thirion+G%22">Thirion G</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Holger+G%22">Holger G</searchLink>; Vascular Patterning Lab, Center for Cancer Biology, VIB, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Mathivet+T%22">Mathivet T</searchLink>; Vascular Patterning Lab, Center for Cancer Biology, VIB, KU Leuven, Leuven, Belgium.; PARCC, HEGP Institute (team 9), INSERM U970, Université Paris Descartes, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vergote+I%22">Vergote I</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Laboratory of Gynecologic Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven (UZ Leuven), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Coosemans+A%22">Coosemans A</searchLink>; ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven (UZ Leuven), Leuven, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2019 Jun 04; Vol. 10, pp. 1273. <i>Date of Electronic Publication: </i>2019 Jun 04 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31214202
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2019.01273
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1273
    Titles:
      – TitleFull: Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baert T
      – PersonEntity:
          Name:
            NameFull: Vankerckhoven A
      – PersonEntity:
          Name:
            NameFull: Riva M
      – PersonEntity:
          Name:
            NameFull: Van Hoylandt A
      – PersonEntity:
          Name:
            NameFull: Thirion G
      – PersonEntity:
          Name:
            NameFull: Holger G
      – PersonEntity:
          Name:
            NameFull: Mathivet T
      – PersonEntity:
          Name:
            NameFull: Vergote I
      – PersonEntity:
          Name:
            NameFull: Coosemans A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 06
              Text: 2019 Jun 04
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1